Notification
No new Notification messages
Enviro Infra Engineers IPO is Open!
Apply for the Enviro Infra Engineers IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
mercury laboratories limited stock

Mercury Laboratories Limited Share Price

928 16.54 (1.81%)
Nov 22 2024 03:30 PM Pharmaceuticals NSE: MERCURYLAB

Mercury Laboratories Limited Share Price Update

As of the latest trading session, Mercury Laboratories Limited share price is currently at 928, which is up by 16.54 from its previous closing. Today, the stock has fluctuated between 928.00 and 928.00. Over the past year, Mercury Laboratories Limited has achieved a return of 16.85 %. In the last month alone, the return has been -6.99 %. Read More...

Mercury Laboratories Limited Performance

Day Range

Low928.00 High928.00
928.00

52 Week Range

Low 721.15 High 1303.00
928.00

Mercury Laboratories Limited Share Price

538964

MERCURYLAB

img img img img
No Data Available

Open Price

928.00

Prev. Close

911.45

Volume (Shares)

14.00

Total traded value

.12

Upper Circuit

1093.70

Lower Circuit

729.20

Note: The current prices & values are delayed, Login to your account for live updates.

Mercury Laboratories Limited Fundamentals


(Standalone)

Market Cap (Cr) 111.40
PE Ratio (TTM) 27.42
Book Value / Share 430.79
Beta 0.24
ROE 11.71%
EPS (TTM) 33.24
Dividend Yield 0.38%
Net Profit Qtr (Cr) 0.50

Mercury Laboratories Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 18.19
Operating Expense 17.75
Net Profit 0.50
Net Profit Margin (%) 2.74
Earnings Per Share (EPS) 4.17
EBITDA 1.51
Effective Tax Rate (%) 23.07
Particulars JUN 2024 (Values in Cr)
Revenue 16.68
Operating Expense 15.91
Net Profit 0.34
Net Profit Margin (%) 2.03
Earnings Per Share (EPS) 2.85
EBITDA 1.76
Effective Tax Rate (%) 63.04
Particulars MAR 2024 (Values in Cr)
Revenue 17.37
Operating Expense 15.53
Net Profit 1.91
Net Profit Margin (%) 10.99
Earnings Per Share (EPS) 15.92
EBITDA 3.07
Effective Tax Rate (%) 15.11
Particulars DEC 2023 (Values in Cr)
Revenue 17.11
Operating Expense 15.70
Net Profit 1.24
Net Profit Margin (%) 7.24
Earnings Per Share (EPS) 10.30
EBITDA 2.41
Effective Tax Rate (%) 22.01
Particulars SEP 2023 (Values in Cr)
Revenue 22.76
Operating Expense 21.08
Net Profit 1.51
Net Profit Margin (%) 6.63
Earnings Per Share (EPS) 12.56
EBITDA 2.84
Effective Tax Rate (%) 25.61
Particulars MAR 2024 (Values in Cr)
Revenue 75.56
Operating Expense 69.72
Net Profit 5.65
Net Profit Margin (%) 7.47
Earnings Per Share (EPS) 47.12
EBITDA 10.12
Effective Tax Rate (%) 18.35
Particulars MAR 2023 (Values in Cr)
Revenue 75.33
Operating Expense 69.61
Net Profit 5.58
Net Profit Margin (%) 7.40
Earnings Per Share (EPS) 46.49
EBITDA 10.28
Effective Tax Rate (%) 25.13
Particulars MAR 2022 (Values in Cr)
Revenue 57.92
Operating Expense 53.84
Net Profit 3.56
Net Profit Margin (%) 6.14
Earnings Per Share (EPS) 29.68
EBITDA 7.93
Effective Tax Rate (%) 29.22
Particulars MAR 2021 (Values in Cr)
Revenue 68.60
Operating Expense 61.57
Net Profit 5.34
Net Profit Margin (%) 7.78
Earnings Per Share (EPS) 44.48
EBITDA 10.47
Effective Tax Rate (%) 32.49
Particulars MAR 2020 (Values in Cr)
Revenue 57.27
Operating Expense 53.79
Net Profit 3.23
Net Profit Margin (%) 5.63
Earnings Per Share (EPS) 26.90
EBITDA 7.02
Effective Tax Rate (%) 25.40
Particulars MAR 2024 (Values in Cr)
Book Value / Share 423.65
ROE % 11.71
ROCE % 13.54
Total Debt to Total Equity 0.12
EBITDA Margin 13.39
Particulars MAR 2023 (Values in Cr)
Book Value / Share 380.24
ROE % 12.99
ROCE % 15.78
Total Debt to Total Equity 0.14
EBITDA Margin 13.66
Particulars MAR 2022 (Values in Cr)
Book Value / Share 335.89
ROE % 9.22
ROCE % 11.81
Total Debt to Total Equity 0.17
EBITDA Margin 13.71
Particulars MAR 2021 (Values in Cr)
Book Value / Share 307.45
ROE % 15.51
ROCE % 19.97
Total Debt to Total Equity 0.21
EBITDA Margin 15.26
Particulars MAR 2020 (Values in Cr)
Book Value / Share 266.48
ROE % 10.60
ROCE % 12.88
Total Debt to Total Equity 0.27
EBITDA Margin 12.26
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.22
Total Assets 67.95
Total Liabilities 67.95
Total Equity 50.83
Share Outstanding 1200000
Price to Book Ratio 1.96
Return on Assets (%) 8.32
Return on Capital (%) 10.04
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.31
Total Assets 64.16
Total Liabilities 64.16
Total Equity 45.62
Share Outstanding 1200000
Price to Book Ratio 1.54
Return on Assets (%) 8.69
Return on Capital (%) 10.94
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.93
Total Assets 62.43
Total Liabilities 62.43
Total Equity 40.30
Share Outstanding 1200000
Price to Book Ratio 1.44
Return on Assets (%) 5.70
Return on Capital (%) 7.84
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 4.86
Total Assets 65.37
Total Liabilities 65.37
Total Equity 36.89
Share Outstanding 1200000
Price to Book Ratio 2.09
Return on Assets (%) 8.16
Return on Capital (%) 12.37
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 2.50
Total Assets 56.29
Total Liabilities 56.29
Total Equity 31.97
Share Outstanding 1200000
Price to Book Ratio 1.05
Return on Assets (%) 5.73
Return on Capital (%) 8.43
Particulars MAR 2024 (Values in Cr)
Net Income 6.92
Cash from Operations 9.48
Cash from Investing -6.27
Cash from Financing -1.04
Net change in Cash 0.91
Free Cash Flow 15.75
Particulars MAR 2023 (Values in Cr)
Net Income 7.44
Cash from Operations 3.55
Cash from Investing -1.05
Cash from Financing -1.01
Net change in Cash 0.38
Free Cash Flow 4.61
Particulars MAR 2022 (Values in Cr)
Net Income 5.03
Cash from Operations 7.10
Cash from Investing -1.89
Cash from Financing -1.23
Net change in Cash 2.06
Free Cash Flow 9.01
Particulars MAR 2021 (Values in Cr)
Net Income 7.90
Cash from Operations 9.58
Cash from Investing -4.61
Cash from Financing -1.23
Net change in Cash 2.35
Free Cash Flow 14.20
Particulars MAR 2020 (Values in Cr)
Net Income 4.32
Cash from Operations 6.71
Cash from Investing -1.14
Cash from Financing -3.32
Net change in Cash 1.02
Free Cash Flow 7.85
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 54.37 31.25 2.96 416.66 37.54 / 77.70
BLISS GVS PHARMA LTD 129.00 16.15 1.34 1358.40 92.25 / 148.95
CIPLA LTD 1465.65 25.64 4.17 118365.23 1165.10 / 1702.00
FERMENTA BIOTECH LIMITED 326.85 113.49 3.31 961.95 145.00 / 354.60
GLAXOSMITHKLINE PHARMA LT 2371.20 50.10 24.01 40169.56 1615.65 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 54.37 47.28 9.24 416.66 37.54 / 77.70
AMRUTAJAN HEALTH LTD 706.05 42.95 6.85 2041.24 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6288.90 122.14 23.14 15722.25 4050.15 / 8139.85
BLISS GVS PHARMA LTD 129.00 16.80 1.32 1358.40 92.25 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 926.90
  • 26 Days 948.90
  • 10 Days 939.50
  • 50 Days 982.00
  • 12 Days 929.70
  • 100 Days 974.50
  • 20 Days 940.60
  • 200 Days 1150.60
912.93
PIVOT
First Resistance 920.52
Second Resistance 929.58
Third Resistance 937.17
First Support 903.87
Second Support 896.28
Third Support 887.22
RSI 45.82
MACD -19.21
Commodity Channel Index (CCI) -122.13
ADX 64.71
Williams % R -40.84

Over 1 Month

down

-6.99

Over 3 Months

down

-3.05

Over 6 Months

down

2.41

Over 1 Year

down

16.85

Over 3 Years

down

14.88

Over 5 Years

down

28.51

Mercury Laboratories Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Mercury Laboratories Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
26.34
Promoter Holdings
73.65
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Shah Dilip Ramanlal Huf Shareholding of Promoter and Promoter Group 310600.0 25.88
Shah Rajendra Ramanlal Huf Shareholding of Promoter and Promoter Group 209050.0 17.42
Janki Rajendra Shah Shareholding of Promoter and Promoter Group 104000.0 8.67
Rajendra Ramanlal Shah Shareholding of Promoter and Promoter Group 85650.0 7.14
Dilip Ramanlal Shah Shareholding of Promoter and Promoter Group 84850.0 7.07
Rajeshri K Shah Public Shareholding 26390.0 2.2
Paresh Ramanlal Shah Shareholding of Promoter and Promoter Group 23650.0 1.97
Kaumudini Rajendra Shah Shareholding of Promoter and Promoter Group 21150.0 1.76
Bharati Bharat Dattani Public Shareholding 19725.0 1.64
Adit Dilipbhai Shah Shareholding of Promoter and Promoter Group 15450.0 1.29
Ketan Babulal Shah Public Shareholding 14724.0 1.23
Bimal Ramanlal Shah Shareholding of Promoter and Promoter Group 14000.0 1.17
Sharad Kanayalal Shah Public Shareholding 13344.0 1.11
Parulben Kiranbhai Laliwala Shareholding of Promoter and Promoter Group 12200.0 1.02
Kishoriben Dilip Shah Shareholding of Promoter and Promoter Group 3300.0 0.28

Mercury Laboratories Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-20 3.5 Final 2023-09-21 Equity shares 2022-09-19 3.5 Final 2022-09-21 Equity shares 2021-09-20 2.0 Final 2021-09-22 Equity shares 2021-02-22 1.5 Interim 2021-02-23 Equity shares 2020-09-21 2.0 Final 2020-09-23 Equity shares 2019-09-19 1.5 Final 2019-09-23 Equity shares 2018-08-31 1.5 Final 2018-09-04 Equity shares 2017-09-15 1.5 Final 2017-09-19 Equity shares 2016-09-15 1.5 Final 2016-09-19 Equity shares 2015-09-16 1.5 Final 2015-09-19 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Mercury Laboratories Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Mercury Laboratories Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Mercury Laboratories Ltd?

Answer Field

The share price of Mercury Laboratories Ltd for NSE is ₹ 0.00 and for BSE is ₹ 928.00.

What is the Market Cap of Mercury Laboratories Ltd?

Answer Field

The market cap of Mercury Laboratories Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 1,11.40 Cr. as of now.

What is the 52 Week High and Low of Mercury Laboratories Ltd?

Answer Field

The 52 Week High and Low of Mercury Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1303.00 and ₹ 721.15.

How to Buy Mercury Laboratories Ltd share?

Answer Field

You can trade in Mercury Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Mercury Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 16.85%.

What is the Current Share Price of Mercury Laboratories Ltd?

Answer Field

Mercury Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 928.00 as on Nov 22 2024 03:30 PM.

What is the Market Cap of Mercury Laboratories Ltd Share?

Answer Field

The market cap of Mercury Laboratories Ltd for NSE ₹ 0.0 & for BSE ₹ 1,11.40 as on Nov 22 2024 03:30 PM.

What is the P/E Ratio of Mercury Laboratories Ltd Share?

Answer Field

As on Nov 22 2024 03:30 PM the price-to-earnings (PE) ratio for Mercury Laboratories Ltd share is 27.42.

What is the PB ratio of Mercury Laboratories Ltd Share?

Answer Field

As on Nov 22 2024 03:30 PM, the price-to-book (PB) ratio for Mercury Laboratories Ltd share is 430.79.

How to Buy Mercury Laboratories Ltd Share?

Answer Field

You can trade in Mercury Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Mercury Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Mercury Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Mercury Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader